Emcure acquires 100% stake in Gennova, sells mRNA business to former director, Sanjay Singh
Published on: July 13, 2026, 8:10 p.m. | Source: The Financial Express
Emcure Pharmaceuticals acquires 12.05% stake in Gennova Biopharmaceuticals from Sanjay Singh for Rs 231.87 crore; Gennova becomes wholly owned subsidiary and focuses on biosimilars, while mRNA business shifts to Immunoscript Life Science.
